Procept BioRobotics(NASDAQ) PRCT

Procept BioRobotics makes robotic systems that help doctors treat enlarged prostates. These robots use water jets to remove tissue without using heat. This technology helps millions of men suffering from uncomfortable urinary symptoms.

Tools for Better Prostate Care

• Robotic Systems: Image-guided platforms that automate surgery for enlarged prostates using pressurized water jets instead of heat.
• Disposable Handpieces: Single-use surgical tools required for every procedure to deliver the high-pressure waterjet treatment.
• FirstAssist AI: Software feature that helps surgeons identify anatomical landmarks and plan precise tissue removal during operations.

Strategic Moves and New Tech

• Received 510(k) clearance for the HYDROS Robotic System in August 2024 to modernize the surgical platform.
• Secured a new Category I CPT code from the American Medical Association effective January 2026 to simplify insurance billing.
• Obtained expanded clearance in August 2023 to treat patients who have an active prostate cancer diagnosis.
• Expanded the direct sales force in the United Kingdom and Japan following recent national reimbursement decisions.

How the Technology Differs

The company uses a heat-free waterjet to remove tissue, which reduces the risk of thermal damage to surrounding nerves. Its systems combine ultrasound and cameras to give surgeons a multidimensional view for precise treatment planning.

Performance by the Numbers

• Quarterly revenue reached $76.4 million in Q4 2025, up 11.9% year-over-year.
• The global install base reached 912 robotic systems as of December 31, 2025.
• Free cash flow was negative $12.2 million in Q4 2025, up 63.7% from the previous year.
• Market capitalization reached $1.8 billion in Q4 2025, down 59.6% year-over-year.

Evolution of the Business

Procept has transitioned from a development-stage company to a commercial-scale robotics provider with a growing global footprint. Its move toward automated, heat-free surgery aims to replace traditional manual procedures in the urology market.